A Study to Evaluate the Effect of Mild, Moderate, and Severe Hepatic Impairment on Pharmacokinetics of Sitravatinib

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

March 12, 2021

Primary Completion Date

July 13, 2022

Study Completion Date

April 13, 2023

Conditions

Hepatic Impairment

Interventions

DRUG

sitravatinib

Trial Locations (5)

Orlando Clinical Research Center, Orlando

Clinical Pharmacology of Miami, Miami

Nucleus Network, Saint Paul

Texas Liver Institute, Austin

Orange County Research Center, Tustin